Related Experiment Video

Updated: May 25, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

Treatment of in-transit melanoma: an opportunity to discover critical knowledge

Georgia M Beasley1, Douglas S Tyler

  • 1Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA.

Oncology (Williston Park, N.Y.)
|February 15, 2012
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

A Melanoma Patient-Derived Xenograft Model
07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

Related Experiment Videos

Last Updated: May 25, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

A Melanoma Patient-Derived Xenograft Model
07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

Related Concept Videos

Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

Articles linked to this work by shared authors, journal, and citation graph.

Evaluating the predictive power of pump-probe imaging contrast of melanin for metastatic outcome: A 71-patient study.

ArXiv·2026

Biodistribution, shedding, and transmissibility of vusolimogene oderparepvec (RP1).

Frontiers in oncology·2026

Neoadjuvant Therapy for Melanoma.

Advances in surgery·2026

The melanocytic transcriptomic state is independently associated with poor overall survival in patients with metastatic melanoma.

Science advances·2026

Breslow Thickness and Microsatellite Detection in Primary Cutaneous Melanoma: Implications for Oncologic Surgeons and Patients.

The American surgeon·2026

Tumor-infiltrating lymphocyte therapy in metastatic vulvar melanoma: A case report and review of the literature.

Gynecologic oncology reports·2026

Advancing Multidisciplinary Care and Health Equity in Metastatic Breast Cancer.

Oncology (Williston Park, N.Y.)·2026

Homologous Recombination and Mismatch Repair Assessment in Men With Advanced Prostate Cancer: A Cross-Sectional Study From a Center in Mexico City.

Oncology (Williston Park, N.Y.)·2026

Access to Care and Drug Prices: Recent Department of Health and Human Services Guidance.

Oncology (Williston Park, N.Y.)·2026

Clinical Outcomes of Acute Pancreatitis in Patients With Multiple Myeloma.

Oncology (Williston Park, N.Y.)·2026

Primary Malignant Melanoma of the Colon: A Rare and Challenging Diagnosis.

Oncology (Williston Park, N.Y.)·2026

Emerging T-Cell Engagers and Novel Immunotargets in Multiple Myeloma.

Oncology (Williston Park, N.Y.)·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us